Overexpression of G6PD is associated with high risks of recurrent metastasis and poor progression-free survival in primary breast carcinoma

The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma

(2014) Rocío Montes de Oca et al.   Molecular Oncology

Relationship between Tumor Heterogeneity Measured on FDG-PET/CT and Pathological Prognostic Factors in Invasive Breast Cancer

(2014) Michael Soussan et al.   PLoS One

Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma

(2013) Toshima Z. Parris et al.   INTERNATIONAL JOURNAL OF CANCER

The prognostic significance of lymphovascular invasion in invasive breast carcinoma

(2011) Emad A. Rakha et al.   CANCER

Overexpression of G6PD is associated with poor clinical outcome in gastric cancer

(2011) Jixu Wang et al.   TUMOR BIOLOGY

AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development

(2010) S. N. Khleif et al.   CLINICAL CANCER RESEARCH

Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood

(2009) Boryana S Stamova et al.   BMC Medical Genomics

A New G6PD Knockdown Tumor-Cell Line with Reduced Proliferation and Increased Susceptibility to Oxidative Stress

(2009) Danyi Li et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Metastasis is promoted by a bioenergetic switch: New targets for progressive renal cell cancer

(2008) Sigrun Langbein et al.   INTERNATIONAL JOURNAL OF CANCER